The development of drugs
Korolkovas, A.
Revista Paulista de Medicina 81(2): 105-126
1973
ISSN/ISBN: 0035-0362 PMID: 4792636 Document Number: 58302
Document emailed within 1 workday
Related Documents
Rygnestad, T. 1992: Development of physostigmine from a poisonous plant to an antidote. one of the most important drugs in the development of modern medicine? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(10): 1300-1303Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556
Powell, R.D. 1972: Development of new antimalarial drugs American Journal of Tropical Medicine and Hygiene 21(5): 744-748
Lu, X.-f.; Chen, Z.-w. 2010: The development of anti-HIV-1 drugs Yao Xue Xue Bao 45(2): 165-176
Vanden Bussche, G.; Gelders, Y.G.; Heylen, S.L. 1990: Development of new antipsychotic drugs Acta Psiquiatrica y Psicologica de America Latina 36(1-2): 13-25
Novácek, L. 1984: 100 years of development of chemical drugs Ceskoslovenska Farmacie 33(10): 444-447
Halford, J.C.G. 2006: Obesity drugs in clinical development Current Opinion in Investigational Drugs 7(4): 312-318
Johnston, T.H.; Brotchie, J.M. 2004: Drugs in development for Parkinson's disease Current Opinion in Investigational Drugs 5(7): 720-726
Grady, R.W.; Graziano, J.H.; White, G.P.; Jacobs, A.; Cerami, A. 1978: The development of new iron-chelating drugs. Ii Journal of Pharmacology and Experimental Therapeutics 205(3): 575
Halford, J.C.G. 2006: Obesity drugs in clinical development Current Opinion in Investigational Drugs 7(4): 312-318
De Micheli, A. 1987: Development of anti-arrhythmic drugs Archivos del Instituto de Cardiologia de Mexico 57(1): 1-8
Carvajal, G. 1976: Biochemical bases in the development of drugs Gaceta Medica de Mexico 111(3): 196-202
Inoue, D. 2015: New anti-osteoporotic drugs under development Nihon Rinsho. Japanese Journal of Clinical Medicine 73(10): 1712-1717
Allain, H.; Lieury, A.; Reymann, J.M.; Martinet, J.P.; Trebon, P.; Decombe, R.; Bentue-Ferrer, D.; Gandon, J.M. 1990: Development of memory-improving drugs Annales de Medecine Interne 141(Suppl 1): 19-25
Weiss, R.B. 1997: New sources and new antitumor drugs in development Seminars in Oncology 24(2): 153-155
Hashiba, S.; Takenaka, Y.; Nakadate, M. 1989: Development of the database on nonproprietary names of drugs Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 1989(107): 141-145
Gorai, I. 2002: Drugs in development for the treatment of osteoporosis: Tibolone Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 3): 552-571
Ballin, J.C. 1981: Contempo '81. Trends in regulation and development of new drugs JAMA 245(21): 2161-2163
Porter, R.J. 1998: Economic factors in the development of new antiepileptic drugs Advances in Neurology 76: 239-244
Simsek, M.; de Boer, N.K.H.; Mulder, C.J.J. 2018: Continued development of drugs: the path of thioguanine Nederlands Tijdschrift Voor Geneeskunde 162: D1757